aktien Suche

Five Prime Therapeutics Inc. Aktie

[FPRX | WKN A1W5T9 | ISIN US33830X1046]
Bid: Ask:

Was macht Five Prime Therapeutics Inc.?


FivePrime is dis­cov­er­ing and devel­op­ing novel ther­a­peu­tic pro­teins and anti­bod­ies by sys­tem­at­i­cally screen­ing all rel­e­vant pro­teins in the human body to find the best pro­tein for treat­ment of a given clin­i­cal indi­ca­tion. FivePrime’s Pro­Screen Engine enables the rapid pro­duc­tion and screen­ing of all ther­a­peu­ti­cally rel­e­vant pro­teins in medically-focused assays at the high­est qual­ity stan­dards in the indus­try. This pow­er­ful approach is the polar oppo­site of the industry’s tra­di­tional “one pro­tein at a time”. The Pro­Screen Engine com­prises the defin­i­tive pro­tein col­lec­tion and screen­ing process for bio­log­ics dis­cov­ery and is unprece­dented in its effi­ciency, qual­ity, and scale. In addi­tion to DBL Investors, investors include Domain Asso­ciates, Ver­sant Ven­tures, Kleiner Perkins Cau­field and Byers, Texas Pacific Group, Health­Cap, and Advanced Tech­nol­ogy Ventures.

Chart der Five Prime Therapeutics Inc. Aktie

Aktuelle Nachrichten zu Five Prime Therapeutics Inc.

Unsere neuesten Artikel zu Five Prime Therapeutics Inc.

Five Prime Therapeutics Inc. Fundamentaldaten

Daten der GuV, Bilanzdaten und wichtige Kennzahlen in übersichtlichen Charts.

Umsatz- und Gewinnentwicklung (jährlich)
Dividende je Aktie im Vergleich zum Gewinn

Five Prime Therapeutics Inc. im Vergleich

Vergleichen Sie Five Prime Therapeutics Inc. mit ähnlichen Unternehmen im Financial Services Sektor.

Kursentwicklung im Vergleich
TraderFox Scoring Systeme